Sanofi company profile

SAN · Euronext Paris · EUR

Compare Sanofi
€86.56Change from previous close: −1.99%Absolute change: −€1.76

Close · November 17, 2026

Company profile

Sanofi has 74,846 employees and is headquartered in Paris, France.

Employing 74,846 people, Sanofi researches, develops, manufactures and markets therapeutic solutions, with a focus on immunology and inflammation, rare diseases, neurology, oncology and vaccines. Its vaccine range includes pediatric vaccines against polio, pertussis and Hib, a hexavalent combination vaccine, protection against respiratory syncytial virus and the Fluzone flu vaccine. Dupixent, developed with Regeneron for diseases driven by type 2 inflammation, is one of its products. Partnerships with companies such as Teva, Kymera Therapeutics and Denali Therapeutics extend its pipeline into areas including ulcerative colitis and genome editing. By region, the US accounts for 50.8% of revenue, other countries for 28.2% and Europe for 21.0%.

Sanofi reported revenue of EUR 46.7 billion in the fiscal year ended December 2025, up 5.5% from the previous year, and net income of EUR 7.8 billion for the same period. The company was incorporated in 1994 as Sanofi-Aventis, changed its name to Sanofi in May 2011 and is headquartered in Paris, France. Its shares also trade on NASDAQ.

Company facts

Industry
Drug Manufacturers - General
Country
France
Headquarters
46, avenue de la Grande ArmEe, 75017, Paris
Employees
74,846
Chief executive
Belen Garijo Lopez
Founded
1994
Fiscal year
January - December
Listing
SAN · Euronext Paris
Indices
CAC 40
Currency
EUR
ISIN
FR0000120578
Website
sanofi.com

Sanofi and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
SanofiSANFrance$116.52B74,84622.3%25.5
GSKGSKUnited Kingdom$102.04B66,84130.5%18.0
Novo NordiskNOVO.BDenmark$184.87B68,79450.8%11.2
BayerBAYNGermany$61.54B87,77516.5%—
AstraZenecaAZNUnited Kingdom$287.12B96,10025.8%26.6
NovartisNOVNSwitzerland$305.16B75,26734.0%32.6

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Sanofi with its competitors